Axel Rosell

1.2k total citations · 1 hit paper
15 papers, 690 citations indexed

About

Axel Rosell is a scholar working on Immunology, Internal Medicine and Infectious Diseases. According to data from OpenAlex, Axel Rosell has authored 15 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Internal Medicine and 4 papers in Infectious Diseases. Recurrent topics in Axel Rosell's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and COVID-19 Clinical Research Studies (4 papers). Axel Rosell is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and COVID-19 Clinical Research Studies (4 papers). Axel Rosell collaborates with scholars based in Sweden, United States and United Kingdom. Axel Rosell's co-authors include Charlotte Thålin, Sebastian Havervall, Nigel Mackman, Mia Phillipson, Katherina Aguilera, Sara M. Mangsbo, Peter Nilsson, Sophia Hober, Fien A. von Meijenfeldt and Ton Lisman and has published in prestigious journals such as JAMA, PLoS ONE and Scientific Reports.

In The Last Decade

Axel Rosell

13 papers receiving 680 citations

Hit Papers

Symptoms and Functional Impairment Assessed 8 Months Afte... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Rosell Sweden 10 304 286 199 175 126 15 690
Parthiban Nadarajan Ireland 10 327 1.1× 195 0.7× 111 0.6× 26 0.1× 135 1.1× 24 576
Arad Dotan Israel 8 209 0.7× 262 0.9× 94 0.5× 80 0.5× 26 0.2× 21 590
Jintao Wang China 7 153 0.5× 284 1.0× 78 0.4× 99 0.6× 22 0.2× 18 507
Liv Osnes Norway 17 61 0.2× 41 0.1× 153 0.8× 381 2.2× 28 0.2× 35 815
Julien Carvelli France 12 182 0.6× 307 1.1× 87 0.4× 164 0.9× 49 0.4× 28 556
Juthaporn Cowan Canada 14 151 0.5× 145 0.5× 64 0.3× 186 1.1× 40 0.3× 55 628
Heather Maioli United States 3 265 0.9× 463 1.6× 63 0.3× 39 0.2× 16 0.1× 6 616
Alexandra Nieters Germany 12 158 0.5× 55 0.2× 99 0.5× 288 1.6× 87 0.7× 28 746
Buğra Kerget Türkiye 12 70 0.2× 166 0.6× 53 0.3× 55 0.3× 12 0.1× 79 453
Olha Halyabar United States 7 209 0.7× 375 1.3× 149 0.7× 169 1.0× 17 0.1× 12 727

Countries citing papers authored by Axel Rosell

Since Specialization
Citations

This map shows the geographic impact of Axel Rosell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Rosell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Rosell more than expected).

Fields of papers citing papers by Axel Rosell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Rosell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Rosell. The network helps show where Axel Rosell may publish in the future.

Co-authorship network of co-authors of Axel Rosell

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Rosell. A scholar is included among the top collaborators of Axel Rosell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Rosell. Axel Rosell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Blasco, A, Axel Rosell, Raquel Castejón, et al.. (2025). Inflammatory and neutrophil extracellular trap markers to predict cardiac events after ST-segment elevation myocardial infarction. PLoS ONE. 20(4). e0319759–e0319759. 1 indexed citations
2.
Meijenfeldt, Fien A. von, Mia Phillipson, Nigel Mackman, et al.. (2025). Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. UNC Libraries.
3.
Hjalmar, Viktoria, Henry Ng, Fay Probert, et al.. (2024). Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms. Inflammation. 48(2). 760–769. 4 indexed citations
4.
Rosell, Axel, et al.. (2023). No indication of aberrant neutrophil extracellular trap release in indolent or advanced systemic mastocytosis. Scandinavian Journal of Immunology. 99(1). e13333–e13333.
5.
Rosell, Axel, Henry Ng, Sebastian Lundström, et al.. (2023). Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism. Journal of Thrombosis and Haemostasis. 21(11). 3166–3174. 12 indexed citations
6.
Hisada, Yohei, Axel Rosell, Sebastian Havervall, et al.. (2023). Tissue factor activity of small and large extracellular vesicles in different diseases. Research and Practice in Thrombosis and Haemostasis. 7(3). 100124–100124. 17 indexed citations
7.
Smith, Philip B., Axel Rosell, Maria Bruzelius, et al.. (2022). Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts. PLoS ONE. 17(7). e0270865–e0270865. 14 indexed citations
8.
Rosell, Axel, Kimberly Martinod, Nigel Mackman, & Charlotte Thålin. (2022). Neutrophil extracellular traps and cancer-associated thrombosis. Thrombosis Research. 213. S35–S41. 31 indexed citations
9.
Rosell, Axel, Katherina Aguilera, Yohei Hisada, et al.. (2021). Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer. Scientific Reports. 11(1). 5074–5074. 27 indexed citations
10.
Havervall, Sebastian, Axel Rosell, Mia Phillipson, et al.. (2021). Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 325(19). 2015–2015. 250 indexed citations breakdown →
11.
Rosell, Axel, Sebastian Havervall, Fien A. von Meijenfeldt, et al.. (2020). Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 878–882. 167 indexed citations
12.
Ng, Henry, Sebastian Havervall, Axel Rosell, et al.. (2020). Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 988–994. 144 indexed citations
13.
Rosell, Axel, et al.. (2020). Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting. Research and Practice in Thrombosis and Haemostasis. 4(6). 1013–1023. 13 indexed citations
14.
Rosell, Axel, Sebastian Lundström, Nigel Mackman, Håkan Wallén, & Charlotte Thålin. (2019). A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism. Journal of Thrombosis and Thrombolysis. 48(1). 111–118. 9 indexed citations
15.
Rosell, Axel, Sebastian Lundström, Håkan Wallén, & Charlotte Thålin. (2018). Performance of the RIETE score in an unselected VTE cohort. Thrombosis Research. 164. S233–S234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026